July 29, 2017 (Shareholders Foundation) - An investigation on behalf of investors of Viewray Inc (NASDAQ:VRAY) shares over potential securities laws violations by Viewray Inc and certain of its directors and officers in connection with certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Viewray Inc (NASDAQ:VRAY) concerning whether a series of statements by Viewray Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Oakwood Village, OH based ViewRay, Inc. designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. Viewray Inc reported that its annual Total Revenue rose from $10.39 million in 2015 to $22.24 million in 2016 and that its Net Loss increased from $44.99 million in 2015 to $50.64 million.

On July 20, 2017, an article was published stating, among other things, that VRAY is another worthless reverse merger stock carefully crafted by a regrouped team of Gottbetter associates (whose principal was imprisoned for fraud) with a horrifying track record including allegations of illegal gambling operations, ties to Organized Crime, a federal investigation and countless stock market implosions.